SMM, which is called sarcopenia, likely occurs because of the rapid weight loss many people experience while taking Ozempic and other GLP-1 drugs
Medical research has established that GLP-1 treatment, under medical surveillance, may result in significant weight loss and some enhancement in some metabolic parameters.Like any other prescription drug, these treatments have side effects and are not applicable to all patients
In clinical results, one-third of patients using Tirzepatide lost at least 25% of their baseline weight, which can represent major progress for patients who need structured medical support
As a best practice for any research supplier, prioritize recent third-party testing, a verified COA, and results from an ISO/IEC 17025accredited laboratory to support identity confirmation and batch-to-batch consistency